{"id":852,"date":"2016-05-05T16:55:22","date_gmt":"2016-05-05T10:55:22","guid":{"rendered":"http:\/\/www.arthosuchak.com\/company-archive\/?p=852"},"modified":"2016-05-05T16:56:05","modified_gmt":"2016-05-05T10:56:05","slug":"postponement-of-40th-annual-general-meeting-of-beximco-pharmaceuticals-limited","status":"publish","type":"post","link":"https:\/\/www.arthosuchak.com\/company-archive\/postponement-of-40th-annual-general-meeting-of-beximco-pharmaceuticals-limited\/","title":{"rendered":"POSTPONEMENT OF 40TH ANNUAL GENERAL MEETING OF BEXIMCO PHARMACEUTICALS LIMITED"},"content":{"rendered":"<p>Pursuant to the Directive issued by the Bangladesh Securities and<\/p>\n<p>Exchange Commission (No.SEC\/SRMIC\/2011\/ 1240\/445) dated April 27,<\/p>\n<p>2016 to follow July-June as income year with effect from July 1, 2016 in<\/p>\n<p>compliance with the provision of the Finance Act 2015, Beximco<\/p>\n<p>Pharmaceuticals Limited announces for the information of the valued<\/p>\n<p>Shareholders of the Company as follows:<\/p>\n<p><a href=\"http:\/\/www.arthosuchak.com\/company-archive\/wp-content\/uploads\/2016\/05\/Announcement-BPL-05.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-large wp-image-855\" src=\"http:\/\/www.arthosuchak.com\/company-archive\/wp-content\/uploads\/2016\/05\/Announcement-BPL-05-757x1024.jpg\" alt=\"Announcement-BPL-05\" width=\"757\" height=\"1024\" srcset=\"https:\/\/www.arthosuchak.com\/company-archive\/wp-content\/uploads\/2016\/05\/Announcement-BPL-05-757x1024.jpg 757w, https:\/\/www.arthosuchak.com\/company-archive\/wp-content\/uploads\/2016\/05\/Announcement-BPL-05-222x300.jpg 222w, https:\/\/www.arthosuchak.com\/company-archive\/wp-content\/uploads\/2016\/05\/Announcement-BPL-05-768x1039.jpg 768w, https:\/\/www.arthosuchak.com\/company-archive\/wp-content\/uploads\/2016\/05\/Announcement-BPL-05.jpg 1453w\" sizes=\"(max-width: 757px) 100vw, 757px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pursuant to the Directive issued by the Bangladesh Securities and Exchange Commission (No.SEC\/SRMIC\/2011\/ 1240\/445) dated April 27, 2016 to follow July-June as income year with effect from July 1, 2016 in compliance with the provision of the Finance Act 2015, Beximco Pharmaceuticals Limited announces for the information of the valued Shareholders of the Company as [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[224],"tags":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/posts\/852"}],"collection":[{"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/comments?post=852"}],"version-history":[{"count":0,"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/posts\/852\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/media?parent=852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/categories?post=852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arthosuchak.com\/company-archive\/wp-json\/wp\/v2\/tags?post=852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}